DEA Archived Press Releases

Press Releases before January 20, 2025
236 Results - Showing 211 to 220
PRESS RELEASE

Manager of Pain Clinic, Her Boyfriend, and Customers Facing Federal Charges for a Drug Distribution Conspiracy

Baltimore, MD – A criminal complaint has been filed charging the manager of a pain clinic, her boyfriend, and several customers with conspiracy to distribute controlled substances, including oxycodone and oxymorphone. The defendants charged in the criminal complaint are: Monica Raynette Clark age 31, of Waldorf, Maryland; Michael Tyrone Scott...
PRESS RELEASE

Bluefield Doctor Sentenced to Federal Prison on Misbranding Charge

ABINGDON, Va. – A family medicine physician in Bluefield, Virginia, was sentenced yesterday to one month in prison on a charge of misbranding Schedule II controlled substances to three individuals, two of whom his office staff called “back door patients.” According to court documents, between December 2014 and January 2016...
PRESS RELEASE

Dark Web Vendor of Opioids and Counterfeit U.S. Currency Pleads Guilty

ALEXANDRIA, Va. – A Utica, New York man pleaded guilty yesterday to charges relating to his sale of over $1.2 million in opioid pills and counterfeit U.S. currency on multiple dark web criminal marketplaces. According to court documents, from around October 2016 through February 2021, Albie Pagan, 65, operated under...
PRESS RELEASE

DEA and SAMHSA announce winners of Red Ribbon Week campus video Public Service Announcement contest

WASHINGTON – The Drug Enforcement Administration and the Substance Abuse and Mental Health Services Administration named North Dakota State College of Science, and the University of Miami winners of the 5th Annual Red Ribbon Week Campus Video PSA Contest. The contest, co-sponsored by DEA and SAMHSA, was part of the...
PRESS RELEASE

DEA 2020 Year in Review: Combatting Serious Drug-Related Threats During the Pandemic

WASHINGTON – With the unprecedented worldwide health emergency brought on by COVID-19, last year was filled with new challenges and increased risks. While much of the world focused on combating the pandemic, DEA continued to implement initiatives to combat violent drug traffickers who were intent on flooding cities and rural...
PRESS RELEASE

Odessa pharmacy and owner to pay $320,000 in civil penalties

EL PASO, Texas -- Odessa pharmacy Town & Country Drug, Inc. (Town & Country) and its owner, pharmacist Gary Warren, have entered into a civil settlement with the United States that requires them to pay $320,000 in civil penalties to resolve allegations that they violated certain provisions of the Controlled...
PRESS RELEASE

DEA encourages communities nationwide to Go Red for Red Ribbon

WASHINGTON – DEA kicked off its 2020 National Red Ribbon Campaign earlier this month with its first-ever virtual National Red Ribbon Rally . This year’s theme is “Be Happy, Be Brave, Be Drug Free” and the rally’s guest speaker was Miss America 2020 Camille Schrier. A Doctor of Pharmacy student...
PRESS RELEASE

Red Ribbon Week kicks off Friday as DEA remembers fallen agent and promotes drug education in communities

OMAHA, Nebraska— The Drug Enforcement Administration (DEA) is kicking off Red Ribbon Week, Friday, October 23, with multiple buildings and bridges across the five state Omaha Division lighting up red to recognize the nation’s oldest and largest drug misuse prevention awareness program. Red Ribbon Week began following the death of...
PRESS RELEASE

DEA celebrates Red Ribbon Week with Virtual Red Ribbon Rally

NEW ORLEANS – The Drug Enforcement Administration will hold its annual National Red Ribbon Rally virtually this year. Our virtual rally will premiere on https://www.dea.gov on October 1, 2020, and be available to share throughout the month of October. This year’s Red Ribbon Rally features voices from our community and...
PRESS RELEASE

DEA Implements Ecommerce Outreach Program to Combat Counterfeit Drug Production

WASHINGTON – The U.S. Drug Enforcement Administration has developed an e-commerce outreach program aimed at reducing the availability of dangerous, often deadly, counterfeit prescription drugs in the United States. This DEA-led initiative focuses on educating online retailers about the sale of pill presses and components used in the production of...